Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 5/20 | 0.55 |
| ▸ | KCNT1 | Q5JUK3 | 1/20 | 0.50 |
| ▸ | AAK1 | Q2M2I8 | 4/20 | 0.42 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.41 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.41 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.40 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.39 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22637906 | 1.00 | S1PR1 (0.55) | S1PR1KCNT1AAK1TLR9TLR8 | |
| SCHEMBL24660777 | 1.00 | S1PR1 (0.55) | S1PR1KCNT1AAK1TLR9TLR8 | |
| SCHEMBL29478734 | 1.00 | S1PR1 (0.55) | S1PR1KCNT1AAK1TLR9TLR8 | |
| SCHEMBL34466001 | 0.91 | S1PR1 (0.47) | S1PR1KCNT1S1PR3HDAC6HDAC1 | |
| SCHEMBL22637680 | 0.88 | HDAC6 (0.43) | S1PR1KCNT1S1PR3HDAC6HDAC1 | |
| SCHEMBL29478772 | 0.88 | HDAC6 (0.43) | S1PR1KCNT1S1PR3HDAC6HDAC1 | |
| SCHEMBL22637681 | 0.88 | HDAC6 (0.43) | S1PR1KCNT1S1PR3HDAC6HDAC1 | |
| SCHEMBL22637495 | 0.86 | S1PR1 (0.46) | S1PR1S1PR3HDAC6HDAC1MAPT | |
| SCHEMBL22637496 | 0.86 | S1PR1 (0.46) | S1PR1S1PR3HDAC6HDAC1MAPT | |
| SCHEMBL29478788 | 0.86 | S1PR1 (0.46) | S1PR1S1PR3HDAC6HDAC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260109692-A1 | KCNT1 INHIBITORS AND METHODS OF USE | UCB Biopharma SRL (BE) | 2026-04-23 | — | — | US | disclosed |
| US-20220259193-A1 | KCNT1 INHIBITORS AND METHODS OF USE | PRAXIS PRECISION MEDICINES, INC. (US) | 2022-08-18 | — | — | US | disclosed |
| CN-114269340-A | KCNT1 inhibitors and methods of use | 普拉克西斯精密药物股份有限公司 | 2022-04-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220259193-A1 | KCNT1 INHIBITORS AND METHODS OF USE | KCNT1, KCNT2, KCNQ2 | S1PR1 3183/4885KCNT1 1/4885AAK1 888/4885 |
| US-20260109692-A1 | KCNT1 INHIBITORS AND METHODS OF USE | KCNT1, KCNJ2, KCNT2 | S1PR1 1005/4885KCNT1 1/4885AAK1 312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.